Publications

Pohlman, F Will, Cassie B. Ford, E Hope Weissler, Michelle M. Smerek, N Chantelle Hardy, Dennis I. Narcisse, Steven J. Lippmann, et al. “Impact of risk factor control on peripheral artery disease outcomes and health disparities.” Vasc Med, April 7, 2022, 1358863X221084360. https://doi.org/10.1177/1358863X221084360.

PMID
35387516
Full Text

Zannad, Faiez, Cynthia Chauhan, Patrick O. Gee, Nick Hartshorne-Evans, Adrian F. Hernandez, Marilyn K. Mann, Robin Martinez, and Roxana Mehran. “Patient partnership in cardiovascular clinical trials.” Eur Heart J 43, no. 14 (April 6, 2022): 1432–37. https://doi.org/10.1093/eurheartj/ehab835.

PMID
34897413
Full Text

Don, C. W., B. A. Zwischenberger, P. A. Kurlansky, S. V. Rao, G. Sharma, J. S. Lawton, and J. E. Tamis-Holland. “2021 ACC/AHA/SCAI Coronary Artery Revascularization Guidelines for Managing the Nonculprit Artery in STEMI.” Jacc: Case Reports 4, no. 7 (April 6, 2022): 377–84. https://doi.org/10.1016/j.jaccas.2022.02.003.

Full Text

Williams, Stephen A., Rachel Ostroff, Michael A. Hinterberg, Josef Coresh, Christie M. Ballantyne, Kunihiro Matsushita, Christian E. Mueller, et al. “A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk.” Sci Transl Med 14, no. 639 (April 6, 2022): eabj9625. https://doi.org/10.1126/scitranslmed.abj9625.

PMID
35385337
Full Text

Kosiborod, Mikhail N., Christiane E. Angermann, Sean P. Collins, John R. Teerlink, Piotr Ponikowski, Jan Biegus, Josep Comin-Colet, et al. “Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospitalized for Acute Heart Failure - Results From the EMPULSE Trial.” Circulation, April 4, 2022. https://doi.org/10.1161/CIRCULATIONAHA.122.059725.

PMID
35377706
Full Text

Lowenstern, Angela, Karen P. Alexander, Neha J. Pagidipati, C Larry Hill, Patricia A. Pellikka, Lawton S. Cooper, Brooke Alhanti, Udo Hoffmann, Daniel B. Mark, and Pamela S. Douglas. “Presenting Symptoms in Patients Undergoing Coronary Artery Disease Evaluation: Association With Noninvasive Test Results and Clinical Outcomes in the PROMISE Trial.” Circ Cardiovasc Qual Outcomes, April 4, 2022, 101161CIRCOUTCOMES121008298. https://doi.org/10.1161/CIRCOUTCOMES.121.008298.

PMID
35369715
Full Text

Singh, Ajay K., Borut Cizman, Kevin Carroll, John J. V. McMurray, Vlado Perkovic, Vivekanand Jha, Kirsten L. Johansen, et al. “Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.” Jama Intern Med, April 4, 2022. https://doi.org/10.1001/jamainternmed.2022.0605.

PMID
35377393
Full Text

Han, Yaling, Bimmer E. Claessen, Shao-Liang Chen, Qiu Chunguang, Yujie Zhou, Yawei Xu, Lin Hailong, et al. “Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy.” Circ Cardiovasc Interv 15, no. 4 (April 2022): e009495. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009495.

PMID
35317615
Full Text

Komisarow, Jordan M., Camilo Toro, Jonathan Curley, Brianna Mills, Christopher Cho, Georges Motchoffo Simo, Monica S. Vavilala, et al. “Utilization of Brain Tissue Oxygenation Monitoring and Association with Mortality Following Severe Traumatic Brain Injury.” Neurocrit Care 36, no. 2 (April 2022): 350–56. https://doi.org/10.1007/s12028-021-01394-y.

PMID
34845596
Full Text

Sharma, Abhinav, Kenneth W. Mahaffey, Charles Michael Gibson, Karen A. Hicks, Karen P. Alexander, Maria Ali, Bernard R. Chaitman, et al. “Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions - proceedings from the CEC Summit 2018.” Am Heart J 246 (April 2022): 93–104. https://doi.org/10.1016/j.ahj.2021.12.012.

PMID
34973948
Full Text

Pages